Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Estrogens and lipid metabolism].

F Berthezène1

  • 1Service d'Endocrinologie et des Maladies de la Nutrition, Laboratoire de métabolisme des lipides, Hôpital de l'Antiquaille, Lyon, France.

Therapie
|September 29, 1999
PubMed
Summary

Menopause alters lipoprotein levels, increasing cardiovascular risk. Hormone therapy, including Selective Oestrogen Receptor Modulators, can positively impact lipid metabolism and cardiovascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The quality-of-life questionnaire QLS-H: validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population].

Annales d'endocrinologie·2004
Same author

[Hormone replacement therapy at menopause in the diabetic woman].

Diabetes & metabolism·2002
Same author

Chronic renal disease.

Lancet (London, England)·2001
Same author

[Is it necessary to systematically treat diabetics by polytherapy at onset? The medical temptation].

Journees annuelles de diabetologie de l'Hotel-Dieu·2001
Same author

PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

The Journal of clinical endocrinology and metabolism·2001
Same author

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Science

Context:

  • Lipoprotein metabolism is influenced by ovarian function in women.
  • Menopause is associated with detrimental changes in lipoprotein profiles, elevating cardiovascular disease (CVD) risk.

Purpose:

  • To review the effects of estrogen therapy and related compounds on lipoprotein metabolism in women.
  • To explore the clinical implications of these metabolic alterations.

Summary:

  • Estrogen therapy influences lipoprotein synthesis and metabolism, generally decreasing low-density lipoprotein (LDL) cholesterol and increasing high-density lipoprotein (HDL) cholesterol, particularly HDL2 and LpA1 fractions.
  • Selective Estrogen Receptor Modulators (SERMs) and phytoestrogens also impact lipid metabolism, offering potential therapeutic benefits.

Impact:

  • Understanding these hormonal influences on lipid profiles is crucial for managing cardiovascular risk in menopausal women.
  • Novel therapeutic strategies targeting estrogen pathways may provide new avenues for lipid management and CVD prevention.

Related Experiment Videos